Gene therapy restores vision in mice; Study: 'Monobodies' control enzymes;

> A group of university investigators say that they used a gene therapy to replace retGC1 and fully restored visual function in a mouse model for Leber congenital amaurosis-1 (LCA1) that persisted for at least 6 months. Release

> Scientists at the University of Chicago Medical Center say they were able to control the activity of enzymes through the use of "synthetic, antibody-like proteins known as monobodies." Release

Suggested Articles

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.